Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center

BACKGROUND: Splenic marginal zone lymphoma (SMZL) is a rare lymphoid B-cell malignant neoplasm with primary involvement of the spleen. It is a chronic disease, of indolent behavior and prolonged survival. However, 25% of cases have higher biological aggressiveness, propensity for histological transf...

Descripción completa

Detalles Bibliográficos
Autores principales: de Pádua Covas Lage, Luís Alberto, dos Santos, Felipe Faganelli Caboclo, Levy, Débora, Moreira, Frederico Rafael, Couto, Samuel Campanelli Freitas, Culler, Hebert Fabrício, de Oliveira Costa, Renata, Rocha, Vanderson, Pereira, Juliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397612/
https://www.ncbi.nlm.nih.gov/pubmed/32746790
http://dx.doi.org/10.1186/s12885-020-07204-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397612/
https://www.ncbi.nlm.nih.gov/pubmed/32746790
http://dx.doi.org/10.1186/s12885-020-07204-6

Ejemplares similares